Christopher Lock
Stanford University
H-index: 18
North America-United States
Top articles of Christopher Lock
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Bridging the Gap Between Science and Practice: The Project BIG Biorepository (P3-6.009) | Anna Tomczak Yamuna Joseph Julia Sumera Tara Tripathi Sarkar Safiyyah Bachar | 2024/4/14 | |
Emerging cerebrospinal fluid biomarkers of disease activity and progression in multiple sclerosis | JAMA neurology | Anne H Cross Jeffrey M Gelfand Simon Thebault Jeffrey L Bennett H Christian Von Büdingen | 2024/4/1 |
Neural Network Corrections to Intermolecular Interaction Terms of a Molecular Force Field Capture Nuclear Quantum Effects in Calculations of Liquid Thermodynamic Properties | Journal of Chemical Theory and Computation | Igor V Kurnikov Leonid Pereyaslavets Ganesh Kamath Serzhan N Sakipov Ekaterina Voronina | 2024/1/19 |
Combining Force Fields and Neural Networks for an Accurate Representation of Bonded Interactions | Journal of the American Chemical Society | Alexey Illarionov Serzhan Sakipov Leonid Pereyaslavets Igor V Kurnikov Ganesh Kamath | 2023/10/19 |
Prevalence, Demographic, and Clinical Factors Associated With Cognitive Dysfunction in Patients With Neuromyelitis Optica Spectrum Disorder | Neurology | Luka Vlahovic Jamie McDonald Jessica Hinman Anna Tomczak Christopher Lock | 2024/1/9 |
The determination of free energy of hydration of water ions from first principles. | Oleg Butin Leonid Pereyaslavets Ganesh Kamath Alexey Illarionov Serzhan Sakipov | 2023/12/13 | |
SARS-CoV-2 Vaccine Immune Response on Anti-Complement Therapy, Eculizumab (P10-5.012) | Neda Sattarnezhad Julia Sumera Jamie McDonald Esther Nie Anna Tomczak | 2023/4/25 | |
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity | Proceedings of the National Academy of Sciences | Koji Shinoda Rui Li Ayman Rezk Ina Mexhitaj Kristina R Patterson | 2023/1/17 |
Progression of Mycosis Fungoides After Fingolimod Treatment for Multiple Sclerosis and Targeted Next-Generation Sequencing Demonstrating Potential Links Between the Two Diseases | JCO Precision Oncology | Saisindhu Narala Yonglu Che Atif Saleem Christopher B Lock Youn H Kim | 2023/1 |
Heerfordt's syndrome with polyradiculopathy, a rare presentation of neurosarcoidosis: Case report and review of literature | Neuroimmunology Reports | Danwei Wu Neda Sattarnezhad Shefali Dujari Christopher Bruce Lock May Han | 2022/1/1 |
Interleukin-6 as a Potential Prognostic Biomarker in Relapsing MOG Antibody Disease (P4-4.004) | Jamie McDonald Neda Sattarnezhad Oskouei Anna Tomczak Julia Sumera Christopher Lock | 2022/5/3 | |
New-onset Headache in Neurosarcoidosis: An Early Sign of Leptomeningeal Involvement.(P11-1.004) | Danwei Wu Anna Tomczak Neda Sattarnezhad Oskouei Jamie McDonald Julia Sumera | 2022/5/3 | |
Cognitive Impairment in Neuromyelitis Optica Spectrum Disorder (NMOSD)(P15-1.003) | Luka Vlahovic Jamie McDonald Jessica Hinman Anna Tomczak Christopher Lock | 2022/5/3 | |
Adaptive B-cell and T-cell responses to SARS-CoV-2 vaccination in patients with Multiple Sclerosis on disease modifying immunotherapy (S5. 006) | Anna Tomczak Julia Sumera Yamuna Joseph Danwei Wu Jamie McDonald | 2022/5/3 | |
Protein–Ligand Binding Free-Energy Calculations with ARROW─ A Purely First-Principles Parameterized Polarizable Force Field | Journal of Chemical Theory and Computation | Grzegorz Nawrocki Igor Leontyev Serzhan Sakipov Mikhail Darkhovskiy Igor Kurnikov | 2022/12/2 |
Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM | Nature | Tobias V Lanz R Camille Brewer Peggy P Ho Jae-Seung Moon Kevin M Jude | 2022/3/10 |
Identification of Novel CSF Measures of Disease Activity and Chronic Progressive Biology in MS: Results of the Ocrelizumab Biomarker Outcome Evaluation Study (OBOE): An Open … | AH Cross JM Gelfand JL Bennett HC von Büdingen B Cameron | 2022/10/1 | |
A variant of uncertain significance in SDHAF1, the succinate dehydrogenase chaperone protein, in an adult patient with spastic paraparesis and leukoencephalopathy | Multiple Sclerosis and Related Disorders | L Vlahovic CB Lock MH Han K Van Haren JB Sampson | 2021/9/1 |
B cells, T cells and inflammatory CSF biomarkers in primary progressive MS and relapsing MS in the OBOE (Ocrelizumab Biomarker Outcome Evaluation) Trial (1635) | Amit Bar-Or Jeffrey Bennett H Von Budingen Robert Carruthers Keith Edwards | 2020/4/14 |
Co-Authors
